Therefore, this study aimed to analyze the distribution of ADA1 and ADA2 in the plasma and CSF of MS patients as well as determine these activities in the human brain microvascular endothelial cells (HBMEC), brain vascular pericytes and astrocytes. Here, ADA2 is linked to myeloid sarcoma.